MARIMED INC by MariMed Inc. Analyst Price Targets - Benzinga

MARIMED INC by MariMed Inc.

MRMDOTCQB

Trade with Public

Trade with Public

$0.0614

0.000350.57%

Últ. Act.: Nov 5, 9:35 AM

Panorámica general Noticias Previsión de beneficiosPrecios objetivoFinanzas Sentimiento Propiedad Comparar

© 2026 Benzinga | All Rights Reserved

MARIMED INC by MariMed Inc. Analyst Price Targets - Benzinga

MARIMED INC by MariMed Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for MARIMED INC by MariMed Inc. (MRMD).

Analyst Consensus — 1 Analysts

1Buy

# Analysts1

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2023	Zuanic & Associates	Pablo Zuanic	Initiate	Overweight	—

Analyst Ratings News

This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More

This week's cannabis news: Snoop Dogg expands his cannabis empire, Planet 13 recovers millions, Glass House locks in $50M & top earnings drop.

Javier Hasse

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Nicolás Jose Rodriguez

Can MariMed's $7.7M Illinois Cannabis Expansion Turn The Tide In A $496M Market?

Despite overall market stagnation, MariMed aims to boost growth through capacity expansion, including a new 14,000 sq ft cultivation site.

Nicolás Jose Rodriguez

Verano, Green Thumb & MariMed's Strong Q2: Unpacking The Cannabis Earnings Surge

In a recent series of equity research reports, Pablo Zuanic of Zuanic & Associates provided a detailed analysis of the Q2 2024 performance for three major players in the cannabis industry: Verano Holdings (OTC: VRNOF), Green Thumb Industries (OTC:&

Nicolás Jose Rodriguez

Cannabis Rescheduling Likely 'In The Next 12 Months,' Says MariMed CEO As Company Invests In Key Markets

Senior analyst Pablo Zuanic hosted a fireside chat Monday evening with Jon Levine, CEO of MariMed Inc. (OTC: MRMD) who outlined the company's operations, growth strategies and financial outlook.

Nicolás Jose Rodriguez

The King Of Ohio's Recreational Cannabis Market? Here's Why Investors Should Follow This Weed Stock

As Ohio begins recreational cannabis sales on August 6, Pablo Zuanic, senior analyst at Zuanic & Associates has initiated coverage of Vext Science (OTC:

Nicolás Jose Rodriguez